Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study

Epilepsia. 2008 Dec;49(12):2092-9. doi: 10.1111/j.1528-1167.2008.01640.x. Epub 2008 May 8.

Abstract

Purpose: To investigate whether the use of antiepileptic drugs (AEDs) increases the risk of hip fracture.

Methods: We performed a case-control study using data from the Funen County (population 2004: 475,000) hip fracture register. Cases (n = 7,557) were all patients admitted to county hospitals with a hip fracture during the period 1996-2004. Controls (n = 27,575) were frequency matched by age and gender. Information on use of AEDs, other drugs, and hospital contacts was available from local registers. Odds ratios (ORs) with 95% confidence intervals (CI) for hip fracture were estimated by unconditional logistic regression.

Results: Fracture risk was increased with ever use of any AED (OR: 1.31; 95% CI: 1.16-1.48). The risk was also increased with use of only enzyme inducing (OR: 1.31; 95% CI: 1.14-1.51), but not with use of only noninducing AEDs (OR: 1.03; 95% CI: 0.77-1.37). Current (OR: 1.92; 95% CI: 1.58-2.33) and recent use, as well as high daily (OR: 1.50; 95% CI: 1.24-1.82) and cumulative dose increased fracture risk, but long treatment duration or previous use did not. The risk was modified by the presence of an epilepsy diagnosis.

Conclusion: Use of AEDs modestly increases the risk of hip fracture. The risk increase is probably associated to a higher degree with a dose dependent effect on CNS with current and recent use, than with an effect on bone tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anticonvulsants / adverse effects*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Confidence Intervals
  • Confounding Factors, Epidemiologic
  • Epilepsy / drug therapy
  • Female
  • Hip Fractures / chemically induced*
  • Hip Fractures / epidemiology*
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Odds Ratio
  • Retrospective Studies
  • Risk*
  • Young Adult

Substances

  • Anticonvulsants